Figure 1.
CART protects NSCs from oxygen glucose deprivation. (A) The morphological mapping of NSCs under a microscope. (B) NSCs were treated with CART55-102 during OGD, cell viability of NSCs was measured using the CCK-8 assay. Date is expressed as mean ± SEM. The experiment was performed in triplicate. (C) Cytotoxicity of NSCs was measured using the LDH assay. Date is expressed as mean ± SEM. The experiment was performed in triplicate. ***p < 0.001, ##p < 0.01, ###p < 0.001.
